72.11.Z - Research and experimental development on biotechnology
47.11.Z - Retail sale in non-specialised stores with food, beverages or tobacco predominating
47.25.Z - Retail sale of alcoholic and non-alcoholic beverages in specialised stores
47.91.Z - Retail sale via mail order houses or via Internet
58.19.Z - Other publishing activities
63.12.Z - Web portals
64.99.Z - Other financial service activities, except insurance and pension funding not elsewhere classified
71.20.A - Food quality testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
73.20.Z - Market research and public opinion polling
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -404,7 | -108,5 | -150,2 | -38,5 |
EBITDA | -402,1 | -105,9 | -148,1 | -39,8 |
Short time liabilities | 21,5 | 119,3 | 216 | 81 |
Equity capital | 187 | 78,5 | 118,3 | 50,7 |
Operating profit (EBIT) | -404,6 | -108,4 | -150,2 | -38,5 |
Assets | 261 | 271,5 | 343,7 | 26,6 |
Net profit (loss) | -404,7 | -108,5 | -150,2 | -38,5 |
Cash | 224,1 | 188,9 | 268,6 | 42,2 |
Net income from sale | 89,7 | 90,9 | 344,7 | 279,4 |
Liabilities and provisions for liabilities | 74 | 193 | 225,4 | 16,8 |
Working assets | 256,4 | 269,4 | 328,4 | 21,9 |
Depreciation | 2,5 | 2,5 | 2,1 | -16,7 |
% | % | % | p.p. | |
Profitability of capital | -216,4 | -138,2 | -127 | 11,2 |
Equity capital to total assets | 71,6 | 28,9 | 34,4 | 5,5 |
Gross profit margin | -451,1 | -119,4 | -43,6 | 75,8 |
EBITDA Margin | -448,2 | -116,6 | -43 | 73,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 87 | 479 | 229 | -250 |
Current financial liquidity indicator | 3.4646778106689453 | 1.3960349559783936 | 3.198671340942383 | 1,8 |
Net dept to EBITDA | 0.5572697520256042 | 1.7832125425338745 | 1.8136613368988037 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane